Next Article in Journal
Resistance to Systemic Agents in Renal Cell Carcinoma Predict and Overcome Genomic Strategies Adopted by Tumor
Next Article in Special Issue
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor
Previous Article in Journal
Treatment Options for Pancreatic Neuroendocrine Tumors
Previous Article in Special Issue
Circulating MACC1 Transcripts in Glioblastoma Patients Predict Prognosis and Treatment Response
 
 
Review

Article Versions Notes

Cancers 2019, 11(6), 829; https://doi.org/10.3390/cancers11060829
Action Date Notes Link
article xml file uploaded 14 June 2019 11:49 CEST Original file -
article xml uploaded. 14 June 2019 11:49 CEST Update -
article pdf uploaded. 14 June 2019 11:49 CEST Version of Record https://www.mdpi.com/2072-6694/11/6/829/pdf-vor
article html file updated 14 June 2019 11:50 CEST Original file -
article pdf uploaded. 18 June 2019 13:54 CEST Updated version of record https://www.mdpi.com/2072-6694/11/6/829/pdf
article xml uploaded. 18 June 2019 13:54 CEST Update -
article xml uploaded. 18 June 2019 13:54 CEST Update https://www.mdpi.com/2072-6694/11/6/829/xml
article html file updated 18 June 2019 13:56 CEST Update -
article html file updated 5 July 2019 19:19 CEST Update -
article html file updated 5 July 2019 19:19 CEST Update -
article html file updated 21 October 2019 21:40 CEST Update -
article html file updated 12 February 2020 19:43 CET Update -
article html file updated 20 July 2022 15:35 CEST Update https://www.mdpi.com/2072-6694/11/6/829/html
Back to TopTop